A critical review of methodological issues and approaches to managing premenstrual syndrome

References

• Beck J. G., Andrasik F., Arena J. G. Group comparison designs. Research Methods in Clinical Psychology, M. Hersen, A. S. Bellack. Pergamon Press, New York 1984; 100–38
   Google Scholar
• Matthews A. Fear reduction research and clinical phobias. Psychol. Bull. 1978; 85: 390–404
   PubMed Web of Science ®Google Scholar
• Frank J. D. The role of hope in psychotherapy. Int. J. Psychiatr. 1968; 5: 383–95
   PubMedGoogle Scholar
• O'Leary K. D., Borkovec T. D. Conceptual, methodological and ethical problems of placebo groups in psychotherapy research. Am. Psychol. 1978; 33: 821–30
   PubMed Web of Science ®Google Scholar
• Wilkins W. Placebo problems in psychotherapy research. Social-psychological alternatives to chemotherapy concepts. Am. Psychol. 1986; 41: 551–6
   PubMed Web of Science ®Google Scholar
• Kazdin A. E., Wilson G. T. Criteria for evaluating psychotherapy. Arch. Gen. Psychiatr. 1978; 35: 407–16
   PubMed Web of Science ®Google Scholar
• Norris R. V. Historical development of progesterone therapy. Premenstrual Syndrome: Ethical and Legal Implications in a Biomedical Perspective, B. E. Ginsburg, B. F. Carter. Plenum Press, New York 1987; 273–85
   Google Scholar
• Israel S. L. Premenstrual tension. J. Am. Med. Assoc. 1938; 110: 1721–3
   Google Scholar
• Jacubowitz D. L., Godard E., Dewhurst J. The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentration. Br. J. Obstet. Gynaecol. 1984; 91: 78–83
   PubMedGoogle Scholar
• Dalton K. Comparative trials of new oral progestagenic compounds in the treatment of the premenstrual syndrome. Br. Med. J. 1959; ii: 1307–9
   Google Scholar
• Dalton K. The Premenstrual Syndrome and Progesterone Therapy. Heinemann, London 1977
   Google Scholar
• Villaneuva B., Caspar R. J., Yen S. S. C. Intravaginal administration of progesterone: enhanced absorption after estrogen treatment. Fertil. Steril. 1981; 35: 33–7
   Web of Science ®Google Scholar
• Steege J. F., Rupp S. L., Stout A. L., et al. Bioavailability of nasally administered progesterone. Fertil. Steril. 1986; 46: 727–9
   PubMed Web of Science ®Google Scholar
• Croxatto H. B., Diaz S., Peralta O., et al. Plasma progesterone levels following subdermal implantation of progesterone pellets in lactating women. Acta Endocrinol. 1982; 100: 630–3
   PubMedGoogle Scholar
• Nillius S. J., Johansson E. D. B. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am. J. Obstet. Gynecol. 1971; 110: 470–7
   PubMed Web of Science ®Google Scholar
• Price J. H., Ismail H., Gorwill R. H., Sarda I. R. Effect of the suppository base on progesterone delivery from the vagina. Fertil. Steril. 1983; 39: 490–3
   PubMed Web of Science ®Google Scholar
• Glazener C. M. A., Bailey I., Hull M. G. R. Effectiveness of vaginal administration of progesterone. Br. J. Obstet. Gynaecol. 1985; 92: 364–8
   PubMedGoogle Scholar
• Van der Meer Y. G., Van Loenen A. C., Loenderbloot E. W., Jaszmann L. J. Plasma progesterone levels after using high dose suppositories: a preliminary report. Pharma. Weekblad. 1982; 4: 135–6
   Google Scholar
• Maxson W. S. The use of progesterone in the treatment of PMS. Clin. Obstet. Gynecol. 1987; 30: 465–77
   PubMed Web of Science ®Google Scholar
• Ferre F., Uzan M., Janssens Y., et al. Oral administration of micronised natural progesterone in late human pregnancy. Am. J. Obstet. Gynaecol. 1984; 148: 26–34
   PubMed Web of Science ®Google Scholar
• Maxson W. S., Hargrove J. T. Bioavailability of oral micronised progesterone. Fertil. Steril. 1985; 44: 622–6
   PubMed Web of Science ®Google Scholar
• Dennerstein L., Spencer-Gardner C., Gotts G., et al. Progesterone and the premenstrual syndrome: a double-blind crossover trial. Br. Med. J. 1985; ii: 1617–21
   Google Scholar
• Sampson G. A. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. Br. J. Psychiatr. 1979; 135: 209–15
   PubMed Web of Science ®Google Scholar
• Van der Meer Y. G., Benedek-Jaszmann L. F., Van Loenen A. C. Effect of high-dose progesterone on the premenstrual syndrome: a double-blind crossover trial. J. Psychosom. Obstet. Gynaecol. 1983; 2: 220–2
   Google Scholar
• Keith G. A study of premenstrual syndrome and progesterone/placebo therapy. Doctoral Dissertation, Walden University, USA 1985
   Google Scholar
• Maddocks S., Hahn P., Moller F., Reid R. L. A double-blind placebo controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am. J. Obstet. Gynaecol. 1986; 154: 573–7
   PubMed Web of Science ®Google Scholar
• Smith S. L., Cleghorn J. M., Steiner D. L. A study of estrogens and progesterone in premenstrual depression. Paper presented to the 4th International Congress of Psychosomatic Obstetrics & Gynaecology, Tel Aviv, 1974
   Google Scholar
• Kerr G. D., Day J. B., Munday M. R., et al. Dydrogesterone in die treatment of premenstrual syndrome. Practitioner 1980; 224: 852–5
   PubMedGoogle Scholar
• Williams J. G. C., Martin A. J., Hulkenberg-Tromp T. E. M.L. PMS in four European countries: part 2. a double-blind placebo controlled study of dydrogesterone. Br. J. Sex. Med. 1983; 10: 8–18
   Google Scholar
• Sampson G. A., Heathcote P. R. M., Wordworth J., Prescott P. Preliminary report: a double-blind crossover study to assess the benefits of dydrogesterone and placebo in premenstrual syndrome. Proceedings of a Workshop on Premenstrual Syndrome, London. R. W. Taylor. 1982
   Google Scholar
• Dennerstein L., Morse C. A., Gotts G., et al. Treatment of premenstrual syndrome: a double-blind trial of dydrogesterone. J. Affect. Dis. 1986; 11: 199–205
   PubMed Web of Science ®Google Scholar
• Norris R. V. Progesterone for premenstrual tension. J Reprod. Med. 1983; 28: 509–16
   PubMed Web of Science ®Google Scholar
• Dennerstein L., Morse C. A., Brown J. B., Smith M. A. Alprazolam in the treatment of premenstrual syndrome. Hormones and Behaviour, L. Dennerstein, I. Fraser. Elsevier/North Holland, Amsterdam 1986; 197–203
   Google Scholar
• Harrison W. M., Endicott J., Nee J. C., Sandberg D. Treatment of premenstrual dysphoria with alprazolam and placebo. Psychopharm. Bull. 1987; 23: 150–3
   PubMedGoogle Scholar
• Smith S., Rinehart J. S., Ruddock V. E., Schiff I. Treatment of premenstrual syndrome with alprazolam, results of a double-blind, placebo-controlled randomised crossover clinical trial. Obstet. Gynecol. 1987; 70: 37–43
   PubMed Web of Science ®Google Scholar
• Andersch B., Hahn L., Wendestam C., et al. Treatment of premenstrual tension syndrome with bromocryptine. Acta Endocrinol. 1978, suppl. 216: 165–74
   Google Scholar
• Graham J. T., Harding P. E., Wise P. H., Berriman H. Prolactin suppression in the treatment of premenstrual syndrome. Med. J. Aust. 1978; 2(suppl. 3)18–20
   PubMedGoogle Scholar
• Kullander S., Svanberg L. Bromocryptine treatment of the premenstrual syndrome. Acta Obstet. Gynaecol. Scand. 1979; 58: 375–8
   PubMed Web of Science ®Google Scholar
• Steiner M., Haskett R., Osmun R. N., et al. Premenstrual tension syndrome: psychoendocrine evaluation and treatment outcome. Psychosom. Med. 1979; 41: 73–7
   Web of Science ®Google Scholar
• Werch A., Kane R. E. Treatment of premenstrual tension with metozalone: a double-blind evaluation of a new diuretic. Curr. Therapeut. Res. 1976; 19: 565–72
   PubMed Web of Science ®Google Scholar
• O'Brien P. M. S., Craven D., Selby C., Symonds E. M. Treatment of premenstrual syndrome with spironolactone. Br. J. Obstet. Gynaecol. 1979; 86: 142–7
   PubMedGoogle Scholar
• Price W. A., Giannini A. J. The use of clonidine in premenstrual tension syndrome. J. Clin. Pharmacol. 1984; 24: 463–5
   PubMed Web of Science ®Google Scholar
• Giannini A. J., Price W. A., Loiselle R. H. Beta-endorphin withdrawal: a possible cause of premenstrual syndrome. Int. J. Psychophys. 1984; 1: 341–3
   PubMed Web of Science ®Google Scholar
• Giannini A. J., Loiselle R. H., Price W. A. Comparison of antimanic efficacy of clonidine and verapamil. J. Clin. Pharmacol. 1985; 25: 307–8
   PubMed Web of Science ®Google Scholar
• Gold M. S., Redmond D. E., Kleiber H. D. Noradrenergic hyperactivity in opiate withdrawal. Am. J. Psychiatr. 1979; 136: 100–2
   PubMed Web of Science ®Google Scholar
• Rees M. C. P. Recent progress in die aetiology of dysmenorrhoea and menorraghia. Functional Disorders of the Menstrual Cycle, M. G. Brush, E. M. Goudsmit. John Wiley, London 1988; 239–50
   Google Scholar
• Jacubowitz D. L., Godard E., Dewhurst J. The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations. Br. J. Obstet. Gynaecol. 1984; 91: 78–83
   PubMedGoogle Scholar
• Lumsden M. A., Kelly R. W., Templeton A. A., et al. Changes in the concentration of prostaglandins in preovulatory human follicles after hCG. J. Reprod. Fertil. 1986; 77: 119–24
   PubMedGoogle Scholar
• Wood C., Jacubowitz D. L. The treatment of premenstrual symptoms with mefenamic acid. Br. J. Obstet. Gynaecol. 1980; 87: 627–32
   PubMedGoogle Scholar
• Budoff P. W. Zomepirac sodium in the treatment of primary dysmenorrhoea syndrome. N. Engl. J. Med. 1982; 307: 714–19
   PubMed Web of Science ®Google Scholar
• Fraser H. M., Baird D. T. Clinical applications of LHRH analogues. Baill. Clin. Endocrinol. Metab. 1987; 1: 43–70
   PubMedGoogle Scholar
• Petri W., Seidel R., Sandow J. A pharmaceutical approach to longterm therapy with peptides. LHRH and its Analogues, F. Labrie, A. Belanger, A. Dupont. Elsevier, Amsterdam 1984; 63–76
   Google Scholar
• Bancroft J., Boyle H., Fraser H. M. The use of an LHRH agonist in the treatment and investigation of the premenstrual syndrome. Proceedings of the 13th Annual Meeting of the International Foundation for Biochemical Endocrinology, K. W. Kerns, G. Fink, A. J. Harmar. Plenum Press, New York 1985; 456–73
   Google Scholar
• Muse K. N., Cetel N. S., Futterman L. A., Yen S. S. C. The premenstrual syndrome: effects of ‘medical ovariectomy’. N. Engl. J. Med. 1984; 311: 1345–9
   PubMed Web of Science ®Google Scholar
• Kendall K. E., Schnurr P. P. The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet. Gynecol. 1987; 70: 145–9
   PubMed Web of Science ®Google Scholar
• Abraham G. E., Hargrove J. T. Effect of vitamin B6 on premenstrual symptomatology in women with premenstrual tension syndromes: a double-blind crossover study. Infertility 1980; 3: 155–61
   Google Scholar
• Frank J. D. Persuasion and Healing: a Comparative Study of Psychotherapy. Johns Hopkins University Press, Baltimore 1973
   Google Scholar
• Elton D., Stanley G., Burrows G. D. The Psychology of Pain. Elsevier/North Holland, Amsterdam 1983; 77–87
   Google Scholar
• Lovibond S. H., Young M. K., Chan D. Behavioural assessment vs. self report of placebo effects. Aust. J. Psychol. 1988; 40: 211–23
   Web of Science ®Google Scholar
• Coyne C. M., Woods N. F., Mitchell E. S. Premenstrual tension syndrome. J. Obstet. Gynecol. Neonat. Nurs. 1985; 14: 446–54
   PubMedGoogle Scholar
• Price W. A., DiMarzio L. R., Gardner P. R. Biopsychosocial approaches to premenstrual syndrome. Am. Fam. Physic 1987; 33: 117–22
   Web of Science ®Google Scholar
• Smith M. A., Youngkin E. Q. Managing me premenstrual syndrome. Clin. Pharmacol. 1986; 5: 788–97
   PubMedGoogle Scholar
• Sommer B. Stress and menstrual distress. J. Hum. Stress 1978; 4: 41–7
   Google Scholar
• Reichlin S., Abplanalp J. M., Labrum A. H., et al. The role of stress in female reproductive dysfunction. J. Hum. Stress June, 1979; 38–45
   PubMedGoogle Scholar
• Woods N. F., Most A., Dery G. K. Estimating perimenstrual distress: comparison of two methods. Res. Nurs. Health 1982; 5: 81–91
   PubMed Web of Science ®Google Scholar
• Timonen S., Procope B.-J. Premenstrual syndrome and physical exercise. Acta Obstet. Gynaecol. Scand. 1971; 50: 331–7
   PubMed Web of Science ®Google Scholar
• Toriola A. L., Mathur D. N. Menstrual dysfunction in Nigerian athletes. Br. J. Obstet. Gynaecol. 1986; 93: 979–85
   PubMedGoogle Scholar
• Kraus H., Raab W. Hypokinetic Disease. Charles C. Thomas, Springfield 1961
   Google Scholar
• Everly G. S. A Clinical Guide to the Treatment of the Human Stress Response. Plenum Press, New York, London 1989, chap 16
   Google Scholar
• Prior J. C., Vigna Y. Conditioning exercise and premenstrual symptoms. J. Reprod. Med. 1987; 32: 423–6
   PubMed Web of Science ®Google Scholar
• Doyne E. J., Chambless D. L., Beutler L. E. Aerobic exercises as a treatment for depression in women. Behav. Ther., 14: 434–40
   Web of Science ®Google Scholar
• Barr Taylor C., Sallis J. F., Needle R. The relation of physical activity and exercise to mental health. Pub. Health Rep. 1985; 100: 195–202
   PubMed Web of Science ®Google Scholar
• Morse C. A., Dennerstcin L. Cognitive therapy for PMS. Functional Disorders of the Menstrual Cycle, M. J. Brush, E. Goudsmit. John Wiley, London 1988; 177–90
   Google Scholar
• Meichenbaum D., Jaremko M. E. Stress Prevention and Treatment. Plenum Press, New York, London 1983
   Google Scholar
• Morse C. A., Bernard M. E., Dcnnerstein L. Rational-emotive therapy (RET) and relaxation in the treatment of premenstrual syndrome: a preliminary study. J. RET. Cog. Ther. 1989; 7: 98–110
   Google Scholar
• Morse C. A., Dennerstein L., Farrell E., Varnavides K. Comparison of coping skills training, hormone therapy and relaxation for the relief of premenstrual syndrome. J. Behav. Med. 1991, in press
   PubMed Web of Science ®Google Scholar
• Hersen M., Barlow D. H. Single Case Experimental Designs: Strategies for Studying Behavior Change, 1st edn. Pergamon Press Inc., New York 1981
   Google Scholar